News

Allero and Abbreos join forces to develop immunotherapy for COVID-19 patients

November 24, 2020

20201124_Press release Allero Therapeutics and Abbreos join forces_FINAL-2

Our other news

Stay informed about the latest updates from Curie Capital and the ongoing activities within our portfolio companies.